Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study

BACKGROUND: Gender affirming hormone therapy (GAHT), whilst considered the standard of care in clinical guidelines for the treatment of many transgender (trans) people is supported by low quality evidence. In this prospective longitudinal controlled study, we aimed to examine the effect of newly com...

Descripción completa

Detalles Bibliográficos
Autores principales: Foster Skewis, Lucas, Bretherton, Ingrid, Leemaqz, Shalem Y., Zajac, Jeffrey D., Cheung, Ada S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358932/
https://www.ncbi.nlm.nih.gov/pubmed/34394009
http://dx.doi.org/10.3389/fendo.2021.717766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358932/
https://www.ncbi.nlm.nih.gov/pubmed/34394009
http://dx.doi.org/10.3389/fendo.2021.717766

Ejemplares similares